Page last updated: 2024-08-24

triazoles and TAK-580

triazoles has been researched along with TAK-580 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ando, K; Kawada, H; Kitamura, Y; Ogawa, Y; Ogiya, D; Suzuki, R1

Other Studies

1 other study(ies) available for triazoles and TAK-580

ArticleYear
Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma.
    International journal of hematology, 2022, Volume: 115, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Drug Synergism; Heterocyclic Compounds, 3-Ring; Humans; Hydrazines; Multiple Myeloma; Triazoles; Tumor Cells, Cultured

2022